The United States of America; as represented by The Secretary; Department of Health and Human Services
发明人:
申请号：
EP16199473.6
公开号：
EP3153861A2
申请日:
2011.08.05
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The invention provides a method for predicting the clinical response to a cancer vaccine in a patient having cancer, a method for determining the immune response to a cancer vaccine in a patient having cancer who has been administered a cancer vaccine, a method for determining the long-term survival in a patient having cancer, corresponding kits therefor, as well as methods of for improving the efficacy of a virus-based vaccine.
